Live Breaking News & Updates on Prnewswire Gilead Sciences Inc

Stay updated with breaking news from Prnewswire gilead sciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030

GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030
vietnamtribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietnamtribune.com Daily Mail and Mail on Sunday newspapers.

Foster City , United States , Alex Kalomparis , Prnewswire Gilead Sciences Inc , Gilead Sciences Inc , Public Affairs , World Health Organization , Gilead Sciences , Grant Program , World Hepatitis Alliance , Providing Grant Funding , South America , North America , Target Projects Focusing , Viral Hepatitis Elimination , Danjuma Kamlen Adda , World Hepatitis , Senior Vice President , Asia Pacific ,

GILEAD SCIENCES ANNOUNCES LAUNCH OF ASIA PACIFIC RAINBOW GRANT 2023

-Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with MoreThan US$4.5 Million Awarded to Organizations across the Asia Pacific Region to Date - - Grant Program in 2023 Invites HIV-Focused Community-Based Organizations to Apply for Funding for Innovative Projects Centered on Theme 'Reducing Stigma & Improving Equity' - SINGAPORE, May 1, 2023 /PRNewswire/ Gilead Sciences, Inc. today announced the launch of its 2023 Asia Pacific Rainbow Grant, marking the fifth anniversary milestone of a regional program which supports community projects to address HIV-related needs in Asia Pacific. Non-profit organizations are invited to submit their applications for 2023 funding online through the Gilead Grant portalstarting today. The submission deadline ends on 28 July 2023, 11:59pm GMT+8. In Asia Pacific, there are still about six million people living with HIV in the region[1] who face social and cultural stigma and punitive laws that preve ....

Foster City , United States , Alex Kalomparis , Asia Pacific Rainbow , Asia Pacific , Prnewswire Gilead Sciences Inc , Gilead Sciences , Public Affairs , Grant Program , Gilead Sciences Inc , Gilead Sciences Celebrates , Fifth Anniversary Milestone , Asia Pacific Rainbow Grant , More Than , Asia Pacific Region , Focused Community Based Organizations , Innovative Projects Centered , Reducing Stigma , Improving Equity , Pacific Rainbow Grant , Gilead Grant , Gilead Asia Pacific Rainbow Grant , Senior Vice President , Ilead Sciences Celebrates The Fifth Anniversary Milestone Of Asia Pacific Rainbow Grant , Ith Morethan Us 4 5 Million Awarded To Organizations Across The Asia Pacific Region Date Grant Program In 2023 Invites Hiv Focused Community Based Apply For Funding Innovative Projects Centered On Theme 39 Reducing Stigma Amp Improving Equity Singapore , May 1 ,

GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS

- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with DAA Therapies - Review of implementation science projects toward HCV Elimination by 2030 in Asia proved effective in improving patient outcomes - Efficacy and safety demonstrated with Bictegravir/Emtricitabine/Tenofovir Alafenamide as compared to Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate as initial treatment in HIV-1/HBV-Coinfected adults SINGAPORE, Feb. 15, 2023 /PRNewswire/ Gilead Sciences Inc. today announced data from multiple studies highlighting the urgency for increased screening, the need for a simplified treatment strategy for Hepatitis C (HCV) infection in the Asia region, and the efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1/HBV-coinfected adults. The data will be presented at the 32nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2023), to be held 15 - ....

National Taiwan University Hospital , T Ai Pei , National Sun Yat Sen University , Kao Hsiung , Bictegravir Emtricitabine Tenofovir Alafenamide , Chun Jen Liu , Emtricitabine Tenofovir Disoproxil Fumarate , Gilead Sciences , Gilead Sciences In Liver Disease , Hepatitis Research Center , Affairs International , Prnewswire Gilead Sciences Inc , Tenofovir Alafenamide , Tenofovir Disoproxil Fumarate , Asian Pacific Association , Senior Vice President , Direct Acting Antivirals , National Taiwan University , Zig Lang , Vice President , Medical Affairs International , Tudy Recommendsa Simplified Strategy For Baseline Testing And Minimal Monitoring Treatment Of Hepatitisc Virus Hcv Infection With Daa Therapies Review Implementation Science Projects Toward Elimination By 2030 In Asia Proved Effective Improving Patient Outcomes Efficacy Safety Demonstrated Bictegravir Emtricitabine Tenofovir Alafenamide As Compared To Dolutegravir Disoproxil Fumarate Initial Hiv 1 Hbv Coinfected Adults Singapore , Feb 15 , 023 Prnewswire Gilead Sciences Inc Today Announced Data From Multiple Studies Highlighting The Urgency For Increased Screening , He Need Fora Simplified Treatment Strategy For Hepatitisc Hcv Infection In The Asia Region , Nd The Efficacy Of Bictegravir Emtricitabine Tenofovir Alafenamidebf Taf In Hiv 1 Hbv Coinfected Adults Data Will Be Presented At 32nd Conference Asian Pacific Association For Study Liver Apasl 2023 ,

GILEAD SCIENCES APPOINTS DUSTIN HAINES AS NEW LEADER FOR ASIA 5 REGION

GILEAD SCIENCES APPOINTS DUSTIN HAINES AS NEW LEADER FOR ASIA 5 REGION
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , South Korea , Jacopo Andreose , Dustin Haines , Washington State University , Gilead Operating Group , Intercontinental Leadership Team , Intercontinental Region Global Patient Solutions , Years In Pharmaceuticals , Prnewswire Gilead Sciences Inc , Haines Brings , Strong Track Record , Global Commercial Successes , Corporate Leadership , Joins Gilead , Company Celebrates , Vice President , General Manager , Next Science , Chief Commercial , Viiv Healthcare , Operating Group , Senior Vice President , Intercontinental Region , Global Patient Solutions ,